Advanced search
Publication Cover
Immunopharmacology and Immunotoxicology Volume 38, 2016 - Issue 3
Submit an article Journal homepage
504
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Anti-human CD138 monoclonal antibodies and their bispecific formats: generation and characterization

Dan ChenThe Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, PR China;
,
Jianxuan ZouThe Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, PR China; ;Abgent (Suzhou) Biotechnology Co., Ltd., Suzhou, Jiangsu, PR China;
,
Yunhui ZongThe Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, PR China; ;Persongen Biomedicine (Suzhou) Co., Ltd., Suzhou, Jiangsu, PR China;
,
Huimin MengThe Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, PR China;
,
Gangli AnThe Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, PR China;
&
Lin YangThe Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu, PR China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, Jiangsu, PR China; ;Suzhou Cancer Immunotherapy-Diagnosis and Nanomedicine Engineering Technology Center, Suzhou, Jiangsu, PR ChinaCorrespondence[email protected]
Pages 175-183 | Received 19 Jul 2015, Accepted 01 Feb 2016, Published online: 08 Mar 2016

References

  • Ibrahim SA, Hassan H, Vilardo L, et al. Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling. PLoS One 2013;8:e85737
  • Raab MS, Podar K, Breitkreutz I, et al. Multiple myeloma. Lancet 2009;374:324–339.
  • Hamers-Casterman C, Atarhouch T, Muyldermans S, et al. Naturally occurring antibodies devoid of light chains. Nature 1993;363:446–448.
  • Baeuerle PA, Reinhardt C. Bispecific T-cell engaging antibodies for cancer therapy. Cancer Res 2009;69:4941–4944.
  • Lutterbuese R, Raum T, Kischel R, et al. T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells. Proc Natl Acad Sci USA 2010;107:12605–12610.
  • Beauvais DM, Rapraeger AC. Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2004;2:3
  • Liebersbach BF, Sanderson RD. Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem 1994;269:20013–20019.
  • Sanderson RD, Sneed TB, Young LA, et al. Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by integral membrane proteoglycan, syndecan. J Immunol 1992;148:3902–3911.
  • Stanley MJ, Liebersbach BF, Liu W, et al. Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. J Biol Chem 1995;270:5077–5083.
  • Dhodapkar MV, Sanderson RD. Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: a multifunctional regulator of cell behavior within the tumor microenvironment. Leuk Lymphoma 1999;34:35–43.
  • Couturier O, Faivre-Chauvet A, Filippovich IV, et al. Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma. Clin Cancer Res 1999;5:3165s–3170s.
  • Maloney DG, Donovan K, Hamblin TJ. Antibody therapy for treatment of multiple myeloma. Semin Hematol 1999;36:30–33.
  • Ragnarsson L, Stromberg T, Wijdenes J, et al. Multiple myeloma cells are killed by syndecan-1-directed superantigen-activated T cells. Cancer Immunol Immunother 2001;50:382–390.
  • Supiot S, Faivre-Chauvet A, Couturier O, et al. Comparison of the biologic effects of MA5 and B-B4 monoclonal antibody labeled with iodine-131 and bismuth-213 on multiple myeloma. Cancer 2002;94:1202–1209.
  • de StGroth SF, Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J Immunol Methods 1980;35:1–21.
  • Zhang GB, Zhou H, Chen YJ, et al. Characterization and application of two novel monoclonal antibodies against 2IgB7-H3: expression analysis of 2IgB7-H3 on dendritic cells and tumor cells. Tissue Antigens 2005;66:83–92.
  • Zou J, Chen D, Zong Y, et al. Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myeloma. Cancer Sci 2015;106:512–521.
  • Vidyasagar P, Sridevi VN, Rajan S, et al. Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs. Eur J Microbiol Immunol (Bp) 2014;4:56–64.
  • Paino T, Sarasquete ME, Paiva B, et al. Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines. PLoS One 2014;9:e92378.
  • Aref S, Goda T, El-Sherbiny M. Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors. Hematology 2003;8:221–228.
  • Mahindra A, Hideshima T, Anderson KC. Multiple myeloma: biology of the disease. Blood Rev 2010;24:S5–S11.
  • Yang Y, Yaccoby S, Liu W. Soluble syndecan-1 promotes growth of myeloma tumors in vivo. promotes of tumors vivo. Blood 2002;100:610–617.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.